Slackbot Users Jump 150%: Can Slack Reignite Salesforce's Growth?

Salesforce reported Slackbot users rose more than 150% sequentially in fiscal Q2 2027, while premium Slack upgrades tripled after launch and Agentforce-related bookings more than doubled quarter over quarter. Q2 revenue increased 11% year over year to $11.35 billion, with subscription and support revenue up 12% to $10.82 billion, supported by Slack and Agentforce adoption. The AI-driven growth opportunity is tempered by competition from Microsoft Copilot/Teams and Zoom AI Companion; CRM shares are down 3.5% year to date, although fiscal 2027 revenue and EPS estimates imply 11.3% and 30.3% growth, respectively.

Analysis

The key underwriting question is not user growth but whether Slack can monetize AI as incremental seat/add-on ARPU without simply discounting bundles. CRM’s low multiple implies skepticism that collaboration can materially alter a core-growth profile; even modest durable reacceleration in net new ARR could drive multiple expansion, but the current evidence is company-reported adoption rather than disclosed AI-specific ARR, retention, or gross-margin contribution. The near-term read-through is favorable for CRM sentiment, yet insufficient to revise revenue estimates absent next-quarter disclosure of paid Slack penetration and Agentforce conversion.

MSFT retains the structural advantage: Teams is embedded in enterprise licensing and Copilot can be funded by Azure economics, making it able to absorb lower collaboration-level returns while defending the control plane. Slack’s viable wedge is cross-cloud workflow interoperability and its installed Salesforce data context; success would raise switching costs for CRM customers, while failure leaves Slack a feature competing with a largely bundled product. ZM is a secondary loser if AI collaboration consolidates around broader suites, although its contact-center cross-sell could partially insulate enterprise revenue.

Over 1-3 months, CRM needs a guidance raise or quantified AI ARR to sustain an outperformance move; otherwise investors are likely to capitalize the announced adoption at a low revenue conversion rate. The contrarian view is that the market may be underestimating operating leverage: if AI upsell is delivered mainly through existing sales capacity and cloud infrastructure, incremental gross profit can translate disproportionately into EPS. Conversely, the fiscal-year earnings step-up followed by a weaker forward EPS trajectory makes the stock vulnerable if management must spend aggressively to defend against Microsoft.

Falsification points: paid Slack/Agentforce attach rates fail to improve sequentially, remaining-performance-obligation growth does not accelerate, or CRM guides subscription growth below the low-double-digit range. On the competitive side, material Microsoft 365/Copilot price concessions or further Teams bundling remedies would respectively pressure or potentially improve Slack’s relative positioning.

Key Decisions for Investors

• Initiate a 3-6 month tactical long CRM / short ZM pair at equal dollar beta: CRM has a plausible AI-monetization rerating catalyst, while ZM faces greater suite-consolidation risk. Target 10-15% relative return; exit if CRM does not quantify paid AI ARR or raise forward revenue outlook at the next earnings report.
• Keep MSFT as the preferred structural AI-workflow exposure rather than chase CRM solely on usage statistics. Add on weakness ahead of the next Azure/Microsoft 365 disclosure; the thesis is falsified by meaningful commercial-cloud deceleration or evidence that Copilot attach is being purchased at uneconomic discounts.
• For CRM, wait for confirmation before adding outright: trigger an overweight only if next-quarter RPO/current-RPO growth and subscription guidance accelerate simultaneously. Without those disclosures, treat the reported adoption metrics as a watch item, not a model-changing catalyst.
• Avoid QBTS: it has no identifiable economic linkage to enterprise collaboration software adoption in the supplied information, and any sympathy bid would be narrative-driven rather than supported by revenue sensitivity.